Preprint
Review

This version is not peer-reviewed.

Effectiveness of the Internet of Things for Improving Health of Non-Pregnant Women Living in High-Income Countries: A Systematic Review

Submitted:

28 October 2025

Posted:

29 October 2025

You are already at the latest version

Abstract

Background/Objectives: There is increased advocacy for the potential for digital applications (Apps) and the Internet of Things (IoT) to improve women’s health. We conducted a systematic review to assess and synthesize the role of Apps and the IoT in improving the health of non-pregnant women. Methods: Six databases were searched from inception to February 13, 2023. We included randomised controlled trials that assessed the effects of various Apps and the IoT with regard to improving the health of non-pregnant women in high-income countries. Our primary outcomes were health status and well-being or quality of life, and we assessed behaviour change as the secondary outcome. Screening, data extraction, and quality assessment were performed in duplicate. Study quality was assessed using the Cochrane Risk of Bias 2.0 tool. Narrative methods were used to synthesise study outcomes. Results: The search retrieved 18,433 publications and seven publications from six studies met the inclusion criteria. Participants included overweight or obese women, postmenopausal women, or women with stage I-III breast cancer. Intervention types varied across included studies but broadly included wearable or sensor-based personal health tracking digital technologies. The most commonly assessed intervention effect was on behaviour change outcomes related to promoting physical activity. Interventions administered yielded positive effects on health outcomes and well-being or quality of life in one study each, while three of the four studies that assessed behaviour change reported significant positive effects. Most included studies had methodological concerns, while study designs and methodologies lacked comparability. Conclusions: Based on our findings, the use of Apps and the IoT may be promising for facilitating behaviour change to promote physical activity. More evidence is needed to assess the effectiveness of the IoT for improving health status, well-being and quality of life among non-pregnant women.

Keywords: 
;  ;  ;  ;  ;  

1. Introduction

Women’s health has historically had an exclusive focus on gynaecological and reproductive health causing a neglect of women’s health needs beyond reproduction [1,2]. However, health priorities for women encompasses much more than reproductive health [3], especially in view of current demographic and epidemiologic transitions. It is well established that women live longer than men globally [4]. However, women are also reported to have more disability and problems with physical functioning during their lifetime compared with men [4,5]. For example, obesity prevalence is higher in women and is more strongly associated with hypertension, cancer and depression than in men [6]. Women are also shown to have higher mortality and worse prognosis after acute cardiovascular events [7].
Despite the conventional viewpoint that women in high-income countries (HICs) tend to utilise more health care [8,9,10] and preventive care services [11], they also face systematic challenges wherein gender differences in disease management are often disadvantageous to women [12]. Hence, gender disparities in access to and quality of healthcare, often leads to delayed diagnosis [13,14] and higher burden of morbidity-driven conditions in women [15]. The ensuing inequality in healthcare has been widely reported [13,14,16] with the underdiagnosis and undertreatment of women attracting attention as a global public health concern [17]. In view of the foregoing, many organisations and societies are prioritising the health of women beyond reproductive health [17,18,19]. Furthermore, there is increased advocacy for the potential for digital health technologies to improve women’s health and promote equity [20].
The World Health Organisation (WHO) defines digital health as a field of knowledge and practice associated with the development and use of digital technologies to improve health [20]. It also encompasses other uses of digital technologies for health such as the Internet of things (IoT). The IoT is a system of interrelated digital devices that are capable of data exchanges over a network without human-to-human or human-to-computer interactions [20,21,22]. Following the introduction of smart healthcare in 2009, attempts to use digital and other technologies to manage information related to people’s health and address healthcare needs have been expanded [23]. Among IoT interventions, smart health care systems are used for disease prevention and health improvement. Smart health care is mainly used in home care, self-care, and acute care settings, where self-care systems allow people to monitor their own health conditions and have access to information through wearable devices and smartphones [21,24]. Accordingly, previous studies have revealed the effectiveness of IoT in improving health outcomes [25,26,27] and encouraging lifestyle behavioural changes [26,27,28,29]. For example, a systematic review on the effectiveness of personalised mobile interventions on lifestyle behaviours within a mixed population (64% of which were women) reported improved lifestyle behaviours [29].
Recently, the IoT is increasingly being leveraged to promote and achieve improvement in women’s health globally. Studies also show that women who wish to participate more in their health issues often use IoT linked devices for day-to-day lifestyle monitoring [28] or management of chronic conditions [22,25]. Examples of application of IoT in women’s health include health monitoring during pregnancy and postpartum period [30], sensor-based menopause transition monitoring [31], interventions for reducing risk of postpartum weight retention [32], and assisted technologies to prevent sarcopenia [33]. Such applications of IoT, which can be used daily and continuously may help address some of the healthcare needs and challenges that women face. Additionally, the use of IoT based applications may provide opportunities and encourage improvements in women’s health by enabling them to make informed choices and engage in healthy lifestyle behaviours. IoT use may also have the potential to reduce gender disparities in healthcare through improved access to required healthcare services.
Types of IoT interventions currently employed for women’s health vary widely, ranging from mobile phones, smart bands and wearable devices for tracking steps, exercise and sleep, to sensor-based devices, or a combination of these which can measure health data and connect to the internet [22,34]. Despite the growing application of IoT to women’s health, the effectiveness of such interventions among non-pregnant women has not been systematically assessed, and there is no true consensus about the effectiveness of the IoT in improving women’s health outcomes [29]. Therefore, a rigorous evaluation that considers all forms of the IoT was planned, for generating evidence and promoting appropriate integration and usage of technologies within existing health systems in order to improve women’s health outcomes [35].

2. Materials and Methods

This review was performed according to the protocol registered in the International Prospective Register of Systematic Reviews (PROSPERO CRD42022384620), and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Table S1) [36]. The protocol for this review was previously published [35].
Search strategy
We performed an electronic search of PubMed (including MEDLINE), Cochrane Central Register of Controlled Trials, Embase, Cumulative Index to Nursing and Allied Health Literature (i.e., CINAHL), and PsycINFO to identify any relevant studies that met our eligibility criteria. We also searched ClinicalTrials.gov (clinicaltrials.gov) and the WHO International Clinical Trials Registry (apps.who.int/trialsearch/) to identify additional ongoing studies. All databases were searched on February 13, 2023, from inception with no restrictions on language or publication dates. The search strategy was developed using keywords and controlled vocabulary related to participants (woman), intervention (IoT e.g., mobile application, wearable electronic device, and smart device), and study design (randomised controlled trials). Consistency in the theme was applied by considering terminological and technical differences between the databases. Supplementary searches also included a backwards citation search of all included studies and systematic reviews. Two experienced librarians developed and executed the search strategy shown in Supplementary S1.
Inclusion and Exclusion Criteria
The inclusion and exclusion criteria were developed using the PICOS criteria for population, intervention, comparison, outcome, and study design (Table 1). Randomised controlled trials (RCT) and cluster-RCT studies examining the role of applications (Apps) and IoT in improving women’s health compared with the use of standard care, no intervention, or another intervention (e.g., education or exercise without IoT) were included. This review included only studies that examined intervention effect among non-pregnant working-aged women. We excluded studies with mixed population unless data was presented separately based on gender or those that included over 80% of female participants who met the inclusion criteria.
Study selection
The results from the database searches were imported into EndNote X9 and de-duplicated. These records were then exported to Rayyan, an online screening tool [37] for title and abstract screening. Twelve review authors (EN, NY, KS, PPT, MOR, MN, GM, KDSL, RS, DS, AN, HH) working independently in pairs conducted the initial title and abstract screening. Following the title and abstract screening, we retrieved full text of studies that were included by at least one reviewer. All stages of screening were conducted in duplicate amongst review authors, and reviewers were blind to each other’s decisions. Any discrepancies in screening decisions were resolved through discussion between the reviewers, or in consultation with a third reviewer when required.
Data Extraction
Six review author pairs (EN, NY, KS, PPT, MOR, MN, GM, KDSL, RS, DS, AN, HH) independently extracted data from the included studies using a predesigned data extraction form in Microsoft Excel (Microsoft Inc). Extracted data included relevant study information (study setting, country, research aims, participants, interventions, comparisons, study design, and outcome measures, including primary and secondary outcomes) and results pertaining to each eligible outcome. Discrepancies were resolved through discussion or by consulting with a third reviewer (EO). In case of any unclear or missing information, attempts were made to contact the authors to collect relevant data.
Risk of Bias Assessment
The quality of the individual studies was assessed using the Cochrane Collaboration’s risk of bias assessment tool 2.0 [38]. Five review author pairs (OOB, NY, KS, PPT, RS, DS, AN, EN, MOR, WMVW) independently assessed the risk of bias for individual review outcomes on each of the following domains: those related to the randomisation process; deviations from intended interventions; missing outcome data; measurement of the outcomes; and selection of the reported results. Supporting text for the judgment of risk of bias domain was provided for each assessment. Risk of bias for each domain and the overall risk of bias for each study was classified into three categories: low risk of bias, some concerns, or high risk of bias. Any discrepancies were resolved through discussion or in consultation with a third reviewer.
Data synthesis
A descriptive overview of the characteristics of the included studies is presented using narrative summaries and tables with key information. We planned to perform network meta-analysis separately on women’s age categories and medical history to estimate the direct, indirect and relative effect of IoT interventions on each outcome. However, the quantitative outcome data were deemed insufficient to pool in a network meta-analysis due to the few numbers of included studies. Also, meta-analysis could not be performed due to heterogeneity in participant characteristics across studies. Results were, therefore summarised in tables and synthesised narratively.

3. Results

3.1. Search Results

The database searches yielded 18,433 records. After duplicates were removed, a total of 13,949 records remained for title and abstract screening. Full texts of 285 potentially eligible studies were retrieved for full text assessment and ineligible studies excluded with reason. No additional references were identified from citation searching (Figure 1). Finally, six studies reported in seven publications fulfilled the inclusion criteria and were included in the review.

3.2. Characteristics of Included Studies

Characteristics of included studies are shown in Table 2. Three studies were carried out in the United States (US) [39,40,41], two in Australia (three reports) [42,43,44] and one study in Canada [45]. Participants were individually randomised in all included studies. Five of the studies used a two-arm design while one study [45] employed a three-arm RCT design. Most of the included studies were small-scale explorations designed to assess the intervention acceptability and feasibility in larger-scale studies. The number of participants ranged from 15 [41] to 83 [43] (Table S2), while the median sample size was 48. The mean age of participants varied across studies with means approximately ranging from 38 [40] to 62 years old [44]. Two studies (three reports) each involved postmenopausal women [39,43,44] or women with stage I-III breast cancer [43,44,45]. Among studies from the US one study included premenopausal women with history of gestational diabetes mellitus (GDM) [41], while two other studies included overweight [39] or obese women [40]. Interventions delivered in the included studies targeted participants with different activity levels including women who were inactive or insufficiently active and moderately active participants. Intervention duration lasted from 6 to 20 weeks, and follow-up periods of up to four months or less were reported.
The summary of intervention characteristics for all included studies is shown in Table 2. Intervention types varied across the studies but broadly included personal health tracking digital technologies. One of the included studies involved a novel sensor device with web portal and smartphone app software designed to assist in performance and compliance of pelvic floor muscle exercises [42]. The other five interventions (six reports) involved participants use of wearable activity monitoring devices to track and record physical activity levels [39,40,43,44,45] or sleep duration and efficiency [41]. Two studies [41,43] were supplemented with a feedback and goal setting sessions further enhanced by telephone delivered behavioural coaching sessions. Similarly, the study by Cadmus-Bertram, et al. [39] focused on promoting physical activity self-monitoring/self-regulating skills among participants. In the study by McNeil, et al. [45], participants received a diary with questions on goal setting, feasibility of prescribed physical activity targets, strategies and barriers to physical activities participation which facilitated follow-up discussions between participants and the study exercise physiologist. The study by Joseph, et al. [40] was a culturally tailored intervention for African American women which featured culturally tailored video and text-based physical activity promotion modules and online discussion board in addition to wearable activity monitors. The interventions in all studies were compared with alternative monitoring techniques or interventions [39,40,41,42], delayed intervention [43,44] or no intervention [45].
Risk of bias assessment
The overview of risk of bias of the included studies is presented in Table 3 and Table S3.
Risk of bias assessment showed that the randomisation domain was rated as having low risk of in three studies (four reports) [39,40,43,44], high risk in one study [42] while two studies had some concerns [41,45]. There was some concern regarding deviations from intended interventions in three studies (four reports) [39,43,44,45], one study was judged to have high risk [42] and two studies had low risk [40,41]. There was some concern with missing outcome data in one study [45] while another study [42] was assessed to have high risk due to lack of information on missing outcome data for study participants. Some outcome measures were based on self-report in four studies [40,41,42,44], while there was no indication that outcome assessors were blinded to intervention groups in five the studies (six reports) [39,41,42,43,44,45]. One study [39] did not report sufficient information on selection of reported results and was judged to have a high risk of bias, while three studies [41,42,43] had some concern with the selection of reported results. Overall bias assessment was judged to be high in three studies [41,42,43,44] and low in only one study [40]. There was some concern with overall bias in two studies [39,45].
Effects of interventions
In this review, intervention effects were categorised into three outcome groups: health status, well-being or quality of life (primary outcomes) and behaviour change (secondary outcome). The most commonly reported intervention effects were behaviour change, reporting changes in physical activity levels [39,40,43,44,45] and sleep patterns [41,45].
Two reports from one study [43,44] examined the effect of a wearable technology activity monitor coupled with behaviour feedback on sedentary behaviour and health related quality of life and fatigue in breast cancer survivors. Two studies [40,45] aimed to increase physical activity level and improve health-related outcomes using activity tracker. The study by Joseph, et al. [40] involved African American women with obesity and assessed the effect of a culturally tailored smartphone-delivered physical activity intervention on changes in level of physical activity and cardiometabolic risk markers. McNeil, et al. [45] used a wrist worn activity tracker to prescribe different physical activity intensities among breast cancer survivors to reduce sedentary time, and improve health outcomes. One study explored the feasibility of technology-assisted
behavioural sleep extension using wearable sleep tracker in women with a history of GDM and short sleep [41]. Edwards, et al. [42] assessed the effect of a novel sensor device with Web Portal and smartphone app designed to assist in the performance of and compliance with pelvic floor muscle exercise in female with urinary incontinence. The summary of intervention types and overall effects is presented in Table 3.
Health status
Outcomes relating to health-related fitness were reported by three studies but varied in terms of the outcomes assessed. Outcomes assessed in the studies included cardiorespiratory fitness (VO2max), body mass index (BMI) or weight change [41,45], cardiometabolic risk markers [40], and blood glucose [41]. Significant increase in VO2max were noted at 12 weeks among the physical activity intervention participants given a wrist-worn device to record heart rate and physical activity intensity and duration throughout the intervention [45]. An increase in VO2max was still noted at 24 weeks, however, these changes were not significantly different than that seen in the control group. No significant changes in body weight or fat mass were reported between baseline and follow up among breast cancer survivors using activity trackers [45] or women with history of GDM and insufficient sleep assigned to the wearable sleep tracker group [41]. Though not statistically significant, Joseph, et al. [40] found clinically relevant between-arm differences across groups wherein intervention participants using the smartphone app-delivered physical activity intervention showed greater improvements in cardiorespiratory fitness, systolic blood pressure, diastolic blood pressure and pulse wave velocity from baseline to 4 months. However, the study found no difference in BMI, inflammatory markers of cardiometabolic health at 4 months [40].
Well-being or quality of life
Three studies reported outcomes related to well-being or quality of life [41,42,44]. Vallance, et al. [44] measured health-related quality of life among post-treatment stage I-III breast cancer patients enrolled in trial that examined the efficacy of a wearable-based intervention to increase physical activity and reduce sedentary behaviours. Statistically significant between group differences were reported whereby the intervention group had a 4.6-point difference in fatigue scores at 12 weeks (95% confidence interval (CI): 1.3, 7.8) indicating improvement in fatigue profiles in the intervention group [44]. No significant differences were observed between groups on the other health-related quality of life variables [44]. In another study, intervention group participants using a wearable sleep tracker had decreased fatigue scores compared to study controls, while no differences were reported between groups for other well-being or quality of life outcomes [41]. Compared to baseline, Edwards, et al. [42] reported improvements in quality of life among females with stress, or stress predominant urinary incontinence randomised to either pelvic floor muscle exercise only or sensor device and pelvic floor muscle exercise groups [42].
Behaviour change
Outcomes relating to behaviour change were reported in almost all the included studies. Five studies reported changes in various levels of physical activity [39,40,41,43,45] while two studies assessed changes in sleep time [41,45]. Two studies [43,45] found that the wearable technology-based physical activity intervention favoured the intervention group, whereby the intervention achieved objectively measured increases in moderate-to-vigorous physical activity [43,45] while at the same time reducing total and prolonged sitting time [43] or sedentary time [45]. In another study, premenopausal women receiving a wearable technology-assisted sleep intervention self-reported statistically significant increases in physical activity compared to controls [41]. Similar self-reported increase in moderate-to-vigorous physical activity physical activity was also reported among participants in a smartphone-delivered physical activity intervention, although there was no observed difference on the accelerometer-measured moderate-to vigorous physical activity [40]. There were also no statistically significant differences between intervention and control groups reported for other objectively measured behaviour change outcomes including time spent standing (min/d), number of sit-stand transitions, number of daily steps [43], and sleep duration [41,45] and efficiency [41]. Alternatively, Cadmus-Bertram, et al. [39] compared two different wearable activity trackers and reported increased moderate-to-vigorous physical activity (in bouts and total) and increased steps per day in the web-based tracking group compared to the pedometer group [39].

4. Discussion

Main findings and comparison with wider literature
This systematic review aimed to synthesise the evidence on the effectiveness of different forms of IoT for improving health outcomes in non-pregnant women living in high-income countries. The current review represents the first comprehensive synthesis focusing exclusively on non-pregnant women in high-income countries, addressing a critical gap in the literature. We included only RCT or cluster-RCT studies examining the role of Apps and the IoT in improving various aspects of women’s health in this review. We identified six unique studies in seven publications that met the review inclusion criteria. Intervention types varied from wearable devices for tracking physical activity, calories, sleep and rest time to sensor device with web portal and smartphone application for pelvic floor muscle exercise. The most frequently evaluated intervention was a wrist-worn device for monitoring physical activity patterns and intensity. While some interventions showed significant positive effect for behaviour change, there was a lack of consistent evidence for improving health status, well-being or quality of life outcomes. Follow-up periods varied across the studies ranging from four weeks to four months, while publication dates were between the year 2015 to 2023. Although some interventions showed promising effects, it is difficult to draw firm conclusions about the use of Apps and IoT for improving women’s health due to limited evidence and heterogeneity in study population and design.
Five of the included studies reported health-related and well-being or quality of live related outcomes. However, the outcomes assessed varied widely across individual studies. Two studies [42,44] that assessed health-related quality of life across different domains had inconsistent findings, reporting significantly positive effects in only one domain among breast cancer survivors [44]. According to previous studies, excess body weight, current smoking and insufficient physical activity are among health behaviour factors associated with poor quality of life among patients undergoing breast cancer treatment [46]. Our findings from this review highlight the potential benefit of IoT interventions for promoting behaviour change. Furthermore, the association between long-term quality of life and fatigue has been established among breast cancer survivors [47]. In the current review, we found evidence to support the association between use of IoT interventions involving wearable technology-based activity monitor, and improvements in fatigue profiles [44] and cardiopulmonary fitness [45].
In relation to the secondary outcomes, four of the five included studies reported on behaviour change related outcomes, including increasing physical activity, reducing sedentary time and improving sleep quality. Among interventions aimed at improving physical activity, statistically significant improvements in moderate-to-vigorous physical activity levels were reported among breast cancer survivors [43,45] and African American women with obesity [40]. The use of wearable technology-based activity tracker provides data based on objective measures of physical activity and sedentary time proving to be valid and reliable tools for measuring and prescribing activity patterns. One of the included studies used a wearable activity tracker to prescribe and monitor different physical activity intensities for breast cancer survivors and showed significant reductions in sedentary time reported among the low-intensity group [45]. A recent viewpoint argued that wearable technology-based devices may be able to facilitate behaviour change through a better understanding of individual preferences, frequency, intensity and duration of prescribed activity based on real-time data [48].
Our review aimed to focus on various IoT used in healthcare, including functions such as technology for relaying medical information through mobile health or telemedicine, collecting data and monitoring. The prominent use of wearable IoT interventions in included studies highlights the growing application of IoT devices for remote patient monitoring and self-management outside of traditional healthcare settings. In addition to the wearable-based IoT interventions, one study included telephone-delivered behavioural counselling [43] while another included text-based physical activity promotion messages and an online discussion board forum [40]. Previous studies have demonstrated the effectiveness of telephone-based care for improving health behaviour [49], self-health management and quality of life among non-pregnant women [50]. Similarly, the use of real-time data sharing of IoT devices along with secure messaging systems that promote direct communication and personalised feedback with healthcare providers may provide unique opportunities for improving women’s health.
The certainty of evidence presented in this narrative summary may be weakened due to methodological variation and differences in the outcome assessment methods. We had planned to perform a meta-analysis for the primary and secondary outcomes in order to compare individual IoT interventions. However, no meta-analysis was done due to variations in outcomes reported on a particular topic which limits the possibility of evidence synthesis, thus making it difficult to make decisions in practice. Also noteworthy is the fact that most studies included in this review were pilot phase intervention trials designed to assess acceptability and feasibility of wearable or sensor-based IoT interventions. Although past research suggest that women find IoT devices such as wearables comfortable, convenient, affordable and effective [22], more large-scale studies are needed to clearly demonstrate intervention effects, safety and scalability of the IoT in women’s healthcare.
Limitations
The current review has several limitations that must be highlighted. Heterogeneity was high among the included studies thereby precluding the possibility to conduct meta-analysis. This was further exacerbated by the multi-component nature of the interventions considered in this review as previously highlighted [48,51]. There was a wide variation across studies and settings in defining what constitutes IoT interventions. The lack of a universally agreed-upon definitions and terminologies for IoT in healthcare creates challenges in determining what constitutes an IoT intervention. While the finding from this systematic review may suggest some positive effect, the single effect of IoT interventions among included studies remains unclear. Despite the rapid growth in the use of IoT worldwide, our review only focused on women living in high-income countries. This focus was deliberate and justified to reduce heterogeneity. As the disease profile and burden among women attracting IoT interventions may differ across high- and low- and middle-income countries, we focused on high-income countries in an effort to reduce heterogeneity in the objectives and settings of IoT interventions. Hence, our findings may not be generalisable to women outside this region.

5. Conclusions

This systematic review aimed to synthesize the role of Apps and the IoT in improving the health of non-pregnant women living in high-income countries. Based on our findings, the use of Apps and the IoT may be promising for facilitating behaviour change to promote physical activity. More evidence is needed to assess the effectiveness of the IoT for improving health status, well-being and quality of life among non-pregnant women.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Supplementary material 1: Search strategy; Table S1: PRISMA Checklist and Abstracts Checklist; Table S2: Search resources details and number of results; Table S3: Description of study phase of included studies; Table S4: Risk of Bias for included studies; Table S5: Intervention effect summary from included studies.

Author Contributions

Conceptualization, N.Y., D.Y., E.S., and E.O.; methodology, N.Y., D.Y., E.S., and E.O.; validation, E.N., and E.O.; formal analysis, O.O.B., E.N., N.Y., K.S., M.O.R., K.dS.L., C.G.M., M.N., P.P.T., R.S., D.S., A.N., and W.M.V.W.; investigation, O.O.B., E.N., N.Y., K.S., M.O.R., K.dS.L., C.G.M., M.N., P.P.T., R.S., D.S., A.N., and W.M.V.W.; resources, E.O.; data curation, O.O.B., and E.N.; writing—original draft preparation, O.O.B.; writing—review and editing, O.O.B., N.Y., M.O.R., K.dS.L., D.S., W.M.V.W.; visualization, O.O.B., and E.N.; supervision, E.S., and E.O.; project administration, E.S., and E.O.; funding acquisition, E.S., and E.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Japan Agency for Medical Research and Development, grant number 22rea522103h0001” and “The APC was funded by JSPS KAKENHI (Grant-in-Aid for Scientific Research (B))” grant Number: 22H03405.

Institutional Review Board Statement

Not applicable

Informed Consent Statement

Not applicable.

Data Availability Statement

Dataset available upon request from the corresponding author.

Acknowledgments

None

Conflicts of Interest

Katharina da Silva Lopes serves as a scientific consultant at NEZU Biotech GmbH, Heidelberg, Germany. All other authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
Apps Digital applications
IoT Internet of Things
HIC High-income countries
WHO World Health Organisation
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
CINAHL Cumulative Index to Nursing and Allied Health Literature
PICOS Population, intervention, comparison, outcome, and study design
RCT Randomised controlled trials
US United States
GDM Gestational diabetes mellitus
BMI Body mass index
CI Confidence interval

References

  1. Bustreo, F.; Knaul, F.M.; Bhadelia, A.; Beard, J.; Carvalho, I.A.d. Women’s health beyond reproduction: meeting the challenges. Bull World Health Organ 2012, 90, 478–478A. [Google Scholar] [CrossRef] [PubMed]
  2. The Lancet. A broader vision for women’s health. Lancet 2023, 402, 347. [Google Scholar] [CrossRef] [PubMed]
  3. Aktar, S.F.; Upama, P.B.; Ahamed, S.I. Leveraging Technology to Address Women’s Health Challenges: A Comprehensive Survey. In Proceedings of the 2024 IEEE 48th Annual Computers, Software, and Applications Conference (COMPSAC); 2024; pp. 941–949. [Google Scholar]
  4. Pinho-Gomes, A.-C.; Peters, S.A.; Woodward, M. Gender equality related to gender differences in life expectancy across the globe gender equality and life expectancy. PLOS Glob Public Health 2023, 3, e0001214. [Google Scholar] [CrossRef]
  5. Crimmins, E.M.; Shim, H.; Zhang, Y.S.; Kim, J.K. Differences between Men and Women in Mortality and the Health Dimensions of the Morbidity Process. Clin Chem 2019, 65, 135–145. [Google Scholar] [CrossRef]
  6. Cooper, A.J.; Gupta, S.R.; Moustafa, A.F.; Chao, A.M. Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep 2021, 10, 458–466. [Google Scholar] [CrossRef]
  7. Gao, Z.; Chen, Z.; Sun, A.; Deng, X. Gender differences in cardiovascular disease. Med Nov Technol Devices 2019, 4, 100025. [Google Scholar] [CrossRef]
  8. Bertakis, K.D.; Azari, R.; Helms, L.J.; Callahan, E.J.; Robbins, J.A. Gender differences in the utilization of health care services. J Fam Pract 2000, 49, 147–152. [Google Scholar]
  9. Lacasse, A.; Nguena Nguefack, H.L.; Page, M.G.; Choinière, M.; Samb, O.M.; Katz, J.; Ménard, N.; Vissandjée, B.; Zerriouh, M. Sex and gender differences in healthcare utilisation trajectories: a cohort study among Quebec workers living with chronic pain. BMJ Open 2023, 13, e070509. [Google Scholar] [CrossRef]
  10. Redondo-Sendino, Á.; Guallar-Castillón, P.; Banegas, J.R.; Rodríguez-Artalejo, F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health 2006, 6, 155. [Google Scholar] [CrossRef]
  11. Vaidya, V.; Partha, G.; Karmakar, M. Gender differences in utilization of preventive care services in the United States. J Womens Health 2012, 21, 140–145. [Google Scholar] [CrossRef] [PubMed]
  12. Regitz-Zagrosek, V. Sex and gender differences in health. Science & Society Series on Sex and Science. EMBO Rep 2012, 13, 596–603. [Google Scholar] [CrossRef] [PubMed]
  13. Mehran, R.; Vogel, B.; Ortega, R.; Cooney, R.; Horton, R. The Lancet Commission on women and cardiovascular disease: time for a shift in women’s health. Lancet 2019, 393, 967–968. [Google Scholar] [CrossRef]
  14. Redfors, B.; Angerås, O.; Råmunddal, T.; Petursson, P.; Haraldsson, I.; Dworeck, C.; Odenstedt, J.; Ioaness, D.; Ravn-Fischer, A.; Wellin, P.; et al. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). J Am Heart Assoc 2015, 4. [Google Scholar] [CrossRef]
  15. Patwardhan, V.; Gil, G.F.; Arrieta, A.; Cagney, J.; DeGraw, E.; Herbert, M.E.; Khalil, M.; Mullany, E.C.; O’Connell, E.M.; Spencer, C.N.; et al. Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Public Health 2024, 9, e282–e294. [Google Scholar] [CrossRef]
  16. Vasiljevic-Pokrajcic, Z.; Krljanac, G.; Lasica, R.; Zdravkovic, M.; Stankovic, S.; Mitrovic, P.; Vukcevic, V.; Asanin, M. Gender Disparities on Access to Care and Coronary Disease Management. Curr Pharm Des 2021, 27, 3210–3220. [Google Scholar] [CrossRef]
  17. Daher, M.; Al Rifai, M.; Kherallah, R.Y.; Rodriguez, F.; Mahtta, D.; Michos, E.D.; Khan, S.U.; Petersen, L.A.; Virani, S.S. Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. Prev Med 2021, 153, 106779. [Google Scholar] [CrossRef] [PubMed]
  18. Clayton, J.A.; Bianchi, D.W.; Hodes, R.; Schwetz, T.A.; Bertagnolli, M. Recent Developments in Women’s Health Research at the US National Institutes of Health. JAMA 2025. [Google Scholar] [CrossRef]
  19. Witt, A.; Womersley, K.; Strachan, S.; Hirst, J.; Norton, R. Women’s health needs beyond sexual, reproductive, and maternal health are missing from the government’s 2024 priorities. BMJ 2024, 384, q679. [Google Scholar] [CrossRef]
  20. World Health Organization. Global strategy on digital health 2020-2025; World Health Organization: Geneva, 2021. [Google Scholar]
  21. Kelly, J.T.; Campbell, K.L.; Gong, E.; Scuffham, P. The Internet of Things: Impact and implications for health care delivery. J Med Internet Res 2020, 22, e20135. [Google Scholar] [CrossRef]
  22. Yoldemir, T. Internet Of Things and women’s health. Climacteric 2020, 23, 423–425. [Google Scholar] [CrossRef]
  23. Tian, S.; Yang, W.; Grange, J.M.L.; Wang, P.; Huang, W.; Ye, Z. Smart healthcare: making medical care more intelligent. Global Health Journal 2019, 3, 62–65. [Google Scholar] [CrossRef]
  24. Srivastava, J.; Routray, S.; Ahmad, S.; Waris, M.M. [Retracted] Internet of Medical Things (IoMT)-Based Smart Healthcare System: Trends and Progress. Comput Intell Neurosci 2022, 2022, 7218113. [Google Scholar] [CrossRef]
  25. An, H.J.; Kang, S.J.; Choi, G.E. Technology-based self-management interventions for women with breast cancer: a systematic review. Korean J Women Health Nurs 2023, 29, 160. [Google Scholar] [CrossRef]
  26. Lu, L.; Huang, T. Effects of Early Nursing Monitoring on Pregnancy Outcomes of Pregnant Women with Gestational Diabetes Mellitus under Internet of Things. Comput Math Methods Med 2022, 2022, 8535714. [Google Scholar] [CrossRef]
  27. Recio-Rodríguez, J.I.; Rodriguez-Sanchez, E.; Martin-Cantera, C.; Martinez-Vizcaino, V.; Arietaleanizbeaskoa, M.S.; Gonzalez-Viejo, N.; Menendez-Suarez, M.; Gómez-Marcos, M.A.; Garcia-Ortiz, L.; on behalf of the, E.I.g. Combined use of a healthy lifestyle smartphone application and usual primary care counseling to improve arterial stiffness, blood pressure and wave reflections: a Randomized Controlled Trial (EVIDENT II Study). Hypertens Res 2019, 42, 852–862. [Google Scholar] [CrossRef]
  28. Azuma, K.; Nojiri, T.; Kawashima, M.; Hanai, A.; Ayaki, M.; Tsubota, K.; on behalf of the, T.R.F.J.S.G. Possible favorable lifestyle changes owing to the coronavirus disease 2019 (COVID-19) pandemic among middle-aged Japanese women: An ancillary survey of the TRF-Japan study using the original “Taberhythm” smartphone app. PLoS One 2021, 16, e0248935. [Google Scholar] [CrossRef] [PubMed]
  29. Tong, H.L.; Quiroz, J.C.; Kocaballi, A.B.; Fat, S.C.M.; Dao, K.P.; Gehringer, H.; Chow, C.K.; Laranjo, L. Personalized mobile technologies for lifestyle behavior change: A systematic review, meta-analysis, and meta-regression. Prev Med 2021, 148, 106532. [Google Scholar] [CrossRef] [PubMed]
  30. Nishimura, E.; Yamaji, N.; Sasayama, K.; Rahman, M.O.; da Silva Lopes, K.; Mamahit, C.G.; Ninohei, M.; Tun, P.P.; Shoki, R.; Suzuki, D.; et al. Effectiveness of the Internet of Things for Improving Pregnancy and Postpartum Women’s Health in High-Income Countries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Healthcare (Basel) 2025, 13. [Google Scholar] [CrossRef] [PubMed]
  31. Luo, J.; Mao, A.; Zeng, Z. Sensor-Based Smart Clothing for Women’s Menopause Transition Monitoring. Sensors 2020, 20, 1093. [Google Scholar] [CrossRef]
  32. Kawasaki, M.; Mito, A.; Waguri, M.; Sato, Y.; Abe, E.; Shimada, M.; Fukuda, S.; Sasaki, Y.; Fujikawa, K.; Sugiyama, T.; et al. Protocol for an interventional study to reduce postpartum weight retention in obese mothers using the internet of things and a mobile application: a randomized controlled trial (SpringMom). BMC Pregnancy Childbirth 2021, 21, 582. [Google Scholar] [CrossRef]
  33. Scott, R.A.; Callisaya, M.L.; Duque, G.; Ebeling, P.R.; Scott, D. Assistive technologies to overcome sarcopenia in ageing. Maturitas 2018, 112, 78–84. [Google Scholar] [CrossRef] [PubMed]
  34. Dang, L.M.; Piran, M.J.; Han, D.; Min, K.; Moon, H. A Survey on Internet of Things and Cloud Computing for Healthcare. Electronics 2019, 8, 768. [Google Scholar] [CrossRef]
  35. Yamaji, N.; Nitamizu, A.; Nishimura, E.; Suzuki, D.; Sasayama, K.; Rahman, M.O.; Saito, E.; Yoneoka, D.; Ota, E. Effectiveness of the Internet of Things for Improving Working-Aged Women’s Health in High-Income Countries: Protocol for a Systematic Review and Network Meta-analysis. JMIR Res Protoc 2023, 12, e45178. [Google Scholar] [CrossRef]
  36. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  37. Ouzzani, M.; Hammady, H.; Fedorowicz, Z.; Elmagarmid, A. Rayyan—a web and mobile app for systematic reviews. Syst Rev 2016, 5, 210. [Google Scholar] [CrossRef]
  38. Higgins, J.P.; Savović, J.; Page, M.J.; Elbers, R.G.; Sterne, J.A. Chapter 8: Assessing risk of bias in a randomized trial; The Cochrane Collaboration: London, 2024; pp. 205–228. [Google Scholar]
  39. Cadmus-Bertram, L.A.; Marcus, B.H.; Patterson, R.E.; Parker, B.A.; Morey, B.L. Randomized trial of a Fitbit-based physical activity intervention for women. Am J Prev Med 2015, 49, 414–418. [Google Scholar] [CrossRef] [PubMed]
  40. Joseph, R.P.; Todd, M.; Ainsworth, B.E.; Vega-López, S.; Adams, M.A.; Hollingshead, K.; Hooker, S.P.; Gaesser, G.A.; Keller, C. Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for Cardiometabolic Risk Reduction among African American Women. Int J Environ Res Public Health 2023, 20. [Google Scholar] [CrossRef]
  41. Reutrakul, S.; Martyn-Nemeth, P.; Quinn, L.; Rydzon, B.; Priyadarshini, M.; Danielson, K.K.; Baron, K.G.; Duffecy, J. Effects of Sleep-Extend on glucose metabolism in women with a history of gestational diabetes: a pilot randomized trial. Pilot Feasibility Stud 2022, 8, 119. [Google Scholar] [CrossRef]
  42. Edwards, A.W.; Sherburn, M.; Rane, A.; Boniface, R.; Smith, D.; O’Hazy, J. A prospective multicentre randomised controlled trial comparing unassisted pelvic floor exercises with PeriCoach System-assisted pelvic floor exercises in the management of female stress urinary incontinence. In Proceedings of the BJU INTERNATIONAL; 2016; pp. 14–15. [Google Scholar]
  43. Lynch, B.M.; Nguyen, N.H.; Moore, M.M.; Reeves, M.M.; Rosenberg, D.E.; Boyle, T.; Vallance, J.K.; Milton, S.; Friedenreich, C.M.; English, D.R. A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial. Cancer 2019, 125, 2846–2855. [Google Scholar] [CrossRef]
  44. Vallance, J.K.; Nguyen, N.H.; Moore, M.M.; Reeves, M.M.; Rosenberg, D.E.; Boyle, T.; Milton, S.; Friedenreich, C.M.; English, D.R.; Lynch, B.M. Effects of the ACTIVity and TEchnology (ACTIVATE) intervention on health-related quality of life and fatigue outcomes in breast cancer survivors. Psychooncology 2020, 29, 204–211. [Google Scholar] [CrossRef] [PubMed]
  45. McNeil, J.; Brenner, D.R.; Stone, C.R.; O’Reilly, R.; Ruan, Y.; Vallance, J.K.; Courneya, K.S.; Thorpe, K.E.; Klein, D.J.; Friedenreich, C.M. Activity Tracker to Prescribe Various Exercise Intensities in Breast Cancer Survivors. Med Sci Sports Exerc 2019, 51, 930–940. [Google Scholar] [CrossRef] [PubMed]
  46. Di Meglio, A.; Havas, J.; Gbenou, A.S.; Martin, E.; El-Mouhebb, M.; Pistilli, B.; Menvielle, G.; Dumas, A.; Everhard, S.; Martin, A.-L. Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy. J Clin Oncol 2022, 40, 3190–3204. [Google Scholar] [CrossRef]
  47. Kim, S.-H.; Jo, H.-Y. Factors Associated with Poor Quality of Life in Breast Cancer Survivors: A 3-Year Follow-Up Study. Cancers 2023, 15, 5809. [Google Scholar] [CrossRef]
  48. Phillips, S.M.; Cadmus-Bertram, L.; Rosenberg, D.; Buman, M.P.; Lynch, B.M. Wearable Technology and Physical Activity in Chronic Disease: Opportunities and Challenges. Am J Prev Med 2018, 54, 144–150. [Google Scholar] [CrossRef]
  49. Derbyshire, E.; Dancey, D. Smartphone Medical Applications for Women’s Health: What Is the Evidence-Base and Feedback? Int J Telemed Appl 2013, 2013, 782074. [Google Scholar] [CrossRef]
  50. Lee, P.-S.; Tsao, L.-I.; Liu, C.-Y.; Lee, C.-L. Effectiveness of Telephone-Based Counseling for Improving the Quality of Life Among Middle-Aged Women. Health Care Women Int 2014, 35, 74–86. [Google Scholar] [CrossRef] [PubMed]
  51. Patel, M.S.; Asch, D.A.; Volpp, K.G. Wearable Devices as Facilitators, Not Drivers, of Health Behavior Change. JAMA 2015, 313, 459–460. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Flow diagram of search results and study selection.
Figure 1. Flow diagram of search results and study selection.
Preprints 182636 g001
Table 1. PICO framework showing review eligibility criteria.
Table 1. PICO framework showing review eligibility criteria.
Inclusion criteria Exclusion criteria
Population (P) Non-pregnant working-aged women
Women living in high-income countries
Studies including men only
Studies including male and female population where outcome data is not separated by gender
Studies of mixed population with <80% female participants
Intervention (I) IoT interventions including applications, smartphones and wearable devices used to improve women’s health IoT interventions targeting pregnancy and postpartum period only
Comparison (C) Standard care
No intervention
Other interventions not utilising IoT
NA
Outcome (O) Primary outcomes
Health status including number of cases diagnosed or treated
Well-being
Quality of life
Secondary outcome
Lifestyle and behavioural changes
Outcomes during pregnancy and postpartum period only
Study design (S) Individual randomised controlled trials (RCTs) and cluster-RCTs
Studies reported in English language
Studies conducted in high-income settings
Review articles
Qualitative studies
Observational studies including cross-sectional studies, case studies
Commentaries, editorials, expert opinions, and letters
Table 2. Characteristics of included studies.
Table 2. Characteristics of included studies.
Study ID (country) Study period Research aim Study design, sample size Participant Intervention(s) Duration Comparison
Lynch, et al. [43] Vallance, et al. [44]
(Australia)
July 2016 – July 2017 To examine the efficacy of a wearable-based intervention to increase moderate to vigorous PA and reduce sedentary behaviours in breast cancer survivors Two-arm individual RCT
N=83
(Intervention=43;
Control=40)
Inactive postmenopausal women diagnosed with stage I-III breast cancer who had completed primary treatment
Mean age: 61.6±6.4
Wearable technology activity monitor (Garmin Viofit 2)
Behavioural feedback and goal-setting session
Telephone-delivered behavioural counselling
12 weeks; follow-up 12 weeks later Delayed intervention
Cadmus-Bertram, et al. [39]
(USA)
2013 – 2014 To evaluate the feasibility and preliminary efficacy of integrating the Fitbit tracker and website into a PA intervention for postmenopausal women Two-arm individual RCT
N=51
(Intervention 25; Control 26)
Participants were overweight postmenopausal women performing 60 minutes/week of MVPA
Mean age: 60.0±7.1
A low-touch, Fitbit-based PA intervention focused on self-monitoring/self-regulation skills 16 weeks; follow-up 4 weeks later Provision of a basic step-counting pedometer
Edwards, et al. [42]
(Australia)
Not described To evaluate the efficacy of the PeriCoach System a novel sensor device with Web Portal and Smartphone app software designed to assist in the performance of and compliance with PFME Two-arm individual RCT
N=22
(Number of people in each group not reported)
Females aged ≥ 18 years with stress, or mixed with predominantly stress, urinary incontinence
Mean age: 42.5
PeriCoach System and PFME 20 weeks PFME
McNeil, et al. [45]
(Canada)
February 2017 – April 2018 To prescribe different PA intensities using activity trackers to increase PA, reduce sedentary time, and improve health outcomes among breast cancer survivors Single centre three armed RCT
N=45
(Interventions 15, 15; Control 15)
Women 18 years or older who have been diagnosed with stage I-IIIc breast cancer and have completed adjuvant treatment
Mean age: 60.0±9.0
Lower or higher-intensity PA. A wrist-worn Polar A360® device to record HR/PA intensity and PA duration throughout the intervention 12 weeks; follow-up 12 weeks later No intervention
Joseph, et al. [40]
(USA)
January
2019 – August 2019
To examine the feasibility and acceptability of a culturally tailored, Social Cognitive Theory-based smartphone-delivered intervention designed to increase PA and reduce cardio metabolic disease risk Two-arm individual RCT
N=60 (Intervention 30; Control 30)
Insufficiently active African American women with obesity aged 24–49 years
Mean age: 38.4±6.9
Smart Walk smartphone-delivered PA intervention. The Smart Walk app included four key features:
Personal profile pages
Culturally tailored video & text-based PA promotion module
Online discussion board forums
PA self-monitoring feature that integrated with Fitbit activity monitors
4 months; follow-up 4 months later Surface-level, culturally tailored health promotion intervention without PA tracking tool, using the same smartphone application platform as the intervention group
Reutrakul, et al. [41] (USA) February 2019 – July 2021 To explore the effects of Sleep-Extend, compared to healthy living control, on sleep and glucose metabolism in women with a history of GDM and insufficient sleep Two-arm individual RCT
N=15 (intervention 9; control 6)
Premenopausal women aged 18–45 years with a history of GDM
Mean age=38.7 - 42.0
Fitbit wearable sleep tracker, with data accessible to the coach for guidance
Fitbit smartphone application offering interactive feedback and tools
Weekly didactic content via email on topics such as healthy sleep education
Weekly brief telephone coaching sessions for reinforcement of didactic content, feedback based on sleep tracker data, progress review, barrier troubleshooting, and goal setting for the following week
6 weeks Weekly health education emails and brief weekly telephone contact with the coach
PA physical activity; RCT- randomised controlled trial; MVPA- moderate to vigorous physical activity; PFME-pelvic floor muscle exercises; HR-heart rate; GDM-gestational diabetes mellitus.
Study ID Intervention Intervention effect between groups Primary outcomes Secondary outcomes Study quality
Health status Well-being or quality of life Behaviour change
Lynch, et al. [43] Vallance, et al. [44]

Wearable technology activity monitor coupled with a behavioural feedback and goal-setting session and telephone-delivered behavioural counselling Significant positive effect Sasaki MVPA (≥2690 cpm, triaxial) High risk of bias

Sasaki MVPA bouts (≥2690 cpm, triaxial)
Freedson MVPA (≥1952 cpm, uniaxial)
Freedson MVPA bouts (≥1952 cpm, uniaxial)
Matthews MVPA bouts (≥760 cpm, uniaxial)
Sitting time, min/d
Sitting time bouts, min/d
No significant difference Matthews MVPA (≥760 cpm, uniaxial)
Standing time
No. of sit-to-stand transitions
No. of steps
Significant positive effect FACIT-Fatigue score (0-52)
No significant difference FACT-B HRQoL Breast cancer sub-scale (0-40)
FACT-B HRQoL trial outcome index (0-96)
FACT-B HRQoL General (0-108)
FACT-B HRQoL total (0-148)
Cadmus-Bertram, et al. [39] Fitbit-based PA intervention focused on self-monitoring / self-regulation skills No significant difference Minutes/week moderate to vigorous intensity PA (total) Some concerns
Minutes/week moderate to vigorous intensity PA (in bouts)
Minutes/week light intensity PA
Average steps/day
Edwards, et al. [42] Sensor device Incontinence Quality-of-Life High risk of bias
McNeil, et al. [45] Wrist-worn Polar A360® device to record HR/PA intensity and PA duration throughout
prescribed 300 min/week of lower-intensity PA or 150 min/week of higher-intensity PA
Significant positive effect Cardiorespiratory fitness VO2max Moderate-vigorous intensity PA time (min/day) Some concerns
Sedentary time (min/day)
No significant difference BMI (kg/m2) Total PA time (min/day)
Light-intensity activity time (min/day)
Sleep time (min/day)
Joseph, et al. [40] Smart Walk smartphone app-delivered PA intervention - Fitbit Inspire HR activity monitor Significant positive effect Self-reported MVPA
(min/week)
Low risk of bias
No significant difference Systolic Blood Pressure (mmHG) Accelerometer-measured MVPA (min/day) - 1-minute bouts
Diastolic Blood Pressure (mmHG) Accelerometer-measured MVPA (min/day) - 10 min bouts
Reutrakul, et al. [41] Fitbit wearable sleep tracker Significant positive effect Promis fatigue T-score IPAQ (MET- minutes/week) High risk of bias
No significant difference Fasting glucose (mg/dL) PSQI Sleep duration (minutes)
2hr glucose (mg/dL) GAD-7 score Sleep efficiency (%)
Weight change (kg) CES-D
MVPA- moderate to vigorous physical activity; FACIT-Fatigue- Functional Assessment of Chronic Illness Therapy-Fatigue; FACT-B- Functional Assessment of Cancer Therapy-Breast; HRQoL-health-related quality of life; PA physical activity; BMI-body mass index; IPAQ- International Physical Activity Questionnaire; PSQI- Pittsburgh Sleep Quality Index; GAD-7- General Anxiety Disorder-7; CES-D- Center for Epidemiologic Studies Depression Scale.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated